REG - Turkiye Garanti Bank - Redemption of the Structured Note

Turkiye Garanti Bankasi ASAnnouncement

29/05/2018 11:35

RNS Number : 5391P
Turkiye Garanti Bankasi
29 May 2018
 


TO: Investment Community
FROM : Garanti Bank / Investor Relations
SUBJECT: TR0GRAN00P62 ISIN-Redemption of the Structured Note
DATE: May 29, 2018
 
The 111-day maturity structured notes, which were issued upon the approval of the Capital Markets Board dated  Feb.15, 2018, by selling to qualified investors on Feb. 7, 2018 with bookbuilding on Feb. 6, 2018 with TR0GRAN00P62 ISIN code and TRY 58,350,290 nominal value, is redeemed on 29.05.2018.




Related Issue Limit Info








Currency Unit


TRY




Limit


20,000,000,000




Issue Limit Security Type


Debt Securities




Sale Type


Sale To Qualified Investors




Domestic / Oversea


Domestic









Capital Market Instrument To Be Issued Info








Type


Structured Note




Maturity Date


29.05.2018




Maturity (Day)


111




Sale Type


Sale To Qualified Investors




ISIN Code


TR0GRAN00P62




Nominal Value of Capital Market Instrument Sold


58,350,290




Currency Unit


TRY









 
In contradiction between the Turkish and English versions of this public disclosure, the Turkish version shall prevail.
 
We declare that our above statements are in conformity with the principles included in the Board's Communiqué, Serial II Nr.15.1, that it exactly reflects the information we received; that the information complies with our records, books and documents; that we did our best to obtain the correct and complete information relative to this subject and that we are responsible for the declarations made in this regard.
 
Yours sincerely,
 
Garanti Bank
Contact Garanti Bank Investor Relations:
Tel: +90 212 318 2352
Fax: +90 212 216 5902
E-mail: investorrelations@garanti.com.tr
www.garantiinvestorrelations.com
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSEWFSUFASEEI